multiple sclerosis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: To be eligible for inclusion in the study, participants had to have received a laboratory-supported diagnosis of relapsing-remitting, secondary progressive or primary progressive MS. In addition, they had to meet the following criteria: competence to give informed consent; age between 30 and 40 years; ability to walk 25 feet with or without a cane or bracing; ability to verbalize a willingness to comply with the study's evaluation schedule. The exclusion criteria were as follows: inability to provide informed consent; EDSS score of 7 or higher; inability to walk 25 feet with the use of an assistive device; pregnancy, breastfeeding, or having given birth within 3 months of initiation of the study; diagnosis of any other neurologic disorder or disability that would affect balance and mobility.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Balance, gait and quality of life. Timepoint: balance(Prior to intervention and after 8 weeks intervention); gait (Prior to intervention and after 8 weeks intervention); quality of life(Prior to intervention and after 8 weeks intervention). Method of measurement: Berg balance test, gait distance in 6 minutes and MSQOL-54 questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| None. Timepoint: none. Method of measurement: none. | — |
Countries
Iran (Islamic Republic of)
Contacts
kharazmi university